GeneProof Hepatitis B Virus (HBV) PCR Kit uses state-of-the-art PCR to detect HBV viral DNA present in specimens
GeneProof
Reagents
Detection threshold: 13,9 IU/ml, with 95% probability
HBV (Hepatitis B Virus) is a dangerous virus that causes the disease of hepatitis B in humans. HBV is the second leading cause of cancer after smoking and is responsible for 60-80% of primary liver cancer cases and 50% of cases of cirrhosis. It is estimated that over 2 billion people worldwide have been or are currently infected with HBV, with approximately 400 million people being HBV carriers, of which 75% are from Asia. Every year, nearly 1 million people die from HBV-related illnesses such as cirrhosis and liver cancer.
Currently, HBV-DNA quantification is one of the important tests for evaluating the effectiveness of hepatitis B treatment and supporting physicians in deciding on treatment protocols.
GeneProof Hepatitis B Virus (HBV) PCR Kit uses state-of-the-art PCR to detect HBV viral DNA present in specimens
Detection target: HBV gennotype A-H, precore mutants HBV (HBeAg negative)
Detection threshold: 13,9 IU/ml, with 95% probability
Based on DNA amplification reaction by PCR reaction with primers designed specifically for HBV DNA sequence, using “hot start” technology to minimize non-specific binding, bringing test results with high accuracy.
The kit includes internal control samples: Control of PCR inhibition and quality of DNA extraction
Master mix contains uracil-DNA-glycosylase (UDG), which minimizes the possibility of cross-contamination during experiments.
GeneProof
Name of product |
Code |
Package |
GeneProof Hepatitis B Virus (HBV) PCR Kit |
HBV/ISEX/025 HBV/ISEX/050 HBV/ISEX/100 |
25 reactions 50 reactions 100 reactions |
The kit enables detection of Adenovirus respiratory species A–D, G and gastrointestinal species E-F
Certificate: ROU
Supplier: Illumina
For Mid and Low-throughput laboratories performing COVID-19 surveillance and identification of new variants
As a product of Panagene (Korea), the PANAMAX ™ 48 automatic extraction device works on the principle of using lysis and binding of samples by magnetic particles. Along with 3 samples kit ready-for-use for the process of extracting DNA/RNA/ccfDNA, this is the solution automatically 100%, just adding the sample to the correct specified wells, the […]
The PANA RealTyper™ HPV Screening Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC
PANA RealTyperTM HPV Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.
The PANA RealTyper™ STD Kit is an in vitro diagnostic reagent for genotyping of 13 pathogens involved in sexually transmitted infections (STI) from vaginal swab and urine.
The PANA RealTyper™ STD Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.
GeneProof PCR Kit is compatible with a wide range of real-time PCR devices to detect the DNA of M.Tuberculosis bacteria present in in specimens.
CE-IVD Quality Certificate for Medical Diagnostic in vitro
GeneProof Hepatitis C Virus (HCV) PCR Kit uses PCR technology to detect HCV virus DNA present in patient samples.
CE-IVD Quality Certificate for Medical Diagnostic Use in vitro